» Articles » PMID: 16251769

Nasal Obstruction, the Airway, and the Athlete

Overview
Date 2005 Oct 28
PMID 16251769
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Rhinitis is a common condition that affects a significant proportion of the general population, as well as a high proportion of athletes. Nasal congestion is a predominate symptom of the late-phase reaction in allergic rhinitis and can have far-reaching effects that extend through the airway and beyond the nose. Rhinitis is often found in conjunction with asthma and is a risk factor for asthma. Nasal obstruction, which does not permit conditioning of inspired air by the nasal turbinates, may contribute to asthma symptoms and the development of asthma. These adverse conditions may be especially troublesome for the high-performance athlete who has increased nasal airflow turbulence and who competes under extreme conditions that may worsen rhinitis and asthma. Under the theory of the unified airway, an immune response induced in the nose may extend into the lungs via cytokines and other inflammatory mediators. Nasal congestion can significantly contribute to sleep dysfunction, leading to daytime fatigue and decreased performance. Treatment of allergic rhinitis can improve sleep and foster productivity. Control of rhinitis and nasal congestion, which is obtained by various therapies, may reverse lower airway tendency to bronchoconstriction.

Citing Articles

Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART).

Ecevit M, Ozcan M, Haberal Can I, Tatar E, Ozer S, Esen E Turk Arch Otorhinolaryngol. 2021; 59(Suppl 1):1-157.

PMID: 34212158 PMC: 8221269. DOI: 10.4274/tao.2021.suppl.1.

References
1.
Hamid Q, Minshall E . Molecular pathology of allergic disease: I: lower airway disease. J Allergy Clin Immunol. 2000; 105(1 Pt 1):20-36. DOI: 10.1016/s0091-6749(00)90172-6. View

2.
Ratner P, Howland 3rd W, Arastu R, Philpot E, Klein K, Baidoo C . Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol. 2003; 90(5):536-42. DOI: 10.1016/S1081-1206(10)61847-9. View

3.
Townley R, Ryo U, Kolotkin B, Kang B . Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol. 1975; 56(6):429-42. DOI: 10.1016/0091-6749(75)90061-5. View

4.
Melo R, Sole D, Naspitz C . Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses. J Allergy Clin Immunol. 2003; 111(2):301-7. DOI: 10.1067/mai.2003.66. View

5.
Inman M, Ellis R, Wattie J, Denburg J, OByrne P . Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol. 1999; 21(4):473-9. DOI: 10.1165/ajrcmb.21.4.3622. View